NCT01339039: Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma |
|
|
| Terminated | 1 | 26 | US | Plerixafor, AMD3100, Mozobil, Bevacizumab, Avastin, Surgery | Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Genzyme, a Sanofi Company | High Grade Glioma: Glioblastoma (GBM), High Grade Glioma: Gliosarcoma, Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Mixed Anaplastic Oligoastrocytoma (AOA) | 04/14 | 04/17 | | |
